Literature DB >> 10447062

Selective induction of endothelial L-selectin ligand in human lung inflammation.

C Collett1, J M Munro.   

Abstract

During inflammation, leukocyte emigration from the circulation can be directed by the endothelium, in part by the inducible endothelial adhesion ligand for L-selectin. In this study, endothelial L-selectin ligand expression was localized by immunohistochemistry in human lung in several different types of lung inflammation and in systemic inflammation. Endothelial L-selectin ligand was not seen in normal lung or in acute pneumonia involving neutrophil accumulation. However, the endothelial ligand was seen in most cases of chronic interstitial pneumonia with mononuclear cell accumulation (a mean of 5.9% of microvessels positive). Regarding granulomatous conditions, in sarcoidosis the endothelial ligand was not identified, but in tuberculous infection some expression was seen in a minority of cases (mean 3.3% of microvessels positive). In contrast, consistent, typically extensive ligand induction (mean 33.4% of microvessels positive) was present in bronchiectatic lung showing prominent lymphocytic accumulation and venules with thickened (high) endothelium, the latter being normally characteristic of lymphoid tissue in which L-selectin ligand is known to be constitutively expressed. Lung from subjects with systemic infection was negative for endothelial expression of the ligand. These studies show how in a defined extralymphoid tissue induction of endothelial L-selectin ligand depended not only on the presence or absence of an inflammatory state, but also on the nature of the inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447062     DOI: 10.1023/a:1003558318903

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  3 in total

Review 1.  L-Selectin ligands in lymphoid tissues and models of inflammation.

Authors:  Adil I Khan; R Clive Landis; Rajneesh Malhotra
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

2.  MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis.

Authors:  Jiahui Fan; Huaping Li; Xiang Nie; Zhongwei Yin; Yanru Zhao; Xudong Zhang; Shuai Yuan; Yuying Li; Chen Chen; Dao Wen Wang
Journal:  Aging (Albany NY)       Date:  2018-09-21       Impact factor: 5.682

Review 3.  High endothelial venules (HEVs) in immunity, inflammation and cancer.

Authors:  Lucas Blanchard; Jean-Philippe Girard
Journal:  Angiogenesis       Date:  2021-05-06       Impact factor: 9.596

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.